1. Home
  2. FSP vs MDWD Comparison

FSP vs MDWD Comparison

Compare FSP & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSP
  • MDWD
  • Stock Information
  • Founded
  • FSP 1981
  • MDWD 2000
  • Country
  • FSP United States
  • MDWD Israel
  • Employees
  • FSP N/A
  • MDWD N/A
  • Industry
  • FSP Real Estate Investment Trusts
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • FSP Real Estate
  • MDWD Health Care
  • Exchange
  • FSP Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • FSP 187.5M
  • MDWD 184.8M
  • IPO Year
  • FSP N/A
  • MDWD 2014
  • Fundamental
  • Price
  • FSP $1.84
  • MDWD $19.28
  • Analyst Decision
  • FSP
  • MDWD Strong Buy
  • Analyst Count
  • FSP 0
  • MDWD 1
  • Target Price
  • FSP N/A
  • MDWD $25.00
  • AVG Volume (30 Days)
  • FSP 365.1K
  • MDWD 62.5K
  • Earning Date
  • FSP 02-24-2025
  • MDWD 11-26-2024
  • Dividend Yield
  • FSP 2.21%
  • MDWD N/A
  • EPS Growth
  • FSP N/A
  • MDWD N/A
  • EPS
  • FSP N/A
  • MDWD N/A
  • Revenue
  • FSP $126,508,000.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • FSP N/A
  • MDWD $10.37
  • Revenue Next Year
  • FSP $0.02
  • MDWD $26.36
  • P/E Ratio
  • FSP N/A
  • MDWD N/A
  • Revenue Growth
  • FSP N/A
  • MDWD N/A
  • 52 Week Low
  • FSP $1.47
  • MDWD $11.04
  • 52 Week High
  • FSP $2.58
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • FSP 49.01
  • MDWD 63.28
  • Support Level
  • FSP $1.69
  • MDWD $15.80
  • Resistance Level
  • FSP $1.90
  • MDWD $18.25
  • Average True Range (ATR)
  • FSP 0.06
  • MDWD 0.87
  • MACD
  • FSP -0.01
  • MDWD 0.15
  • Stochastic Oscillator
  • FSP 57.69
  • MDWD 91.58

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: